Hemodialysis
Conditions
Interventions
None listed
Sponsors
Kawashima Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who continue to use the same dialysate for 3 years or more Stable maintaining dialysis patient
Exclusion criteria
Exclusion criteria: Patients with peritoneal dialysis combined
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mortality rate Hospitalization rate, re-hospitalization rate Corrected Ca, P, intact-PTH, Mg Abdominal CT:calcification score | — |
Secondary
| Measure | Time frame |
|---|---|
| Coronary artery CT: calcification score Vascular endothelial function (FMD) Intima-media complex thickness (IMT): upper arm IMT, carotid IMT ABI PWV Echocardiography: left atrium diameter (LAD), left ventricular end diastolic diameter (LADd), left ventricular ejection fraction (EF), extended early wave (e '), expanded early wave / extended early wave (E / e' ), Left ventricular mass coefficient (LVMI), ventricular septal thickness (IVS), left ventricular wall thickness (LVWT) Electrocardiogram: QTc Prescription drugs and injections (at the beginning and at the end / at the time of death): phosphorus adsorbents, vitamin D preparations, calcium receptor agonists, Mg-containing preparations Frequency of dialysis hypotension requiring replacement fluid Nutritional status: PCR, GNRI,% CGR, BMI, Alb, TP, ChE Periodic blood collection results: Hb, Ht, BUN, Cre, Na, Cl, Fe, ferritin, blood glucose (GA, HbA1c), B2-MG | — |
Countries
Japan
Contacts
Public ContactYusaku Tanaka
Kawashima Hospital Clinical Engineering
Outcome results
None listed